Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension

BACKGROUND: Patient treatment satisfaction is likely to be a highly relevant outcome measure in pulmonary arterial hypertension (PAH), a condition for which the benefits of treatment must be weighed against frequent, undesirable side effects, inconvenience, and complications associated with therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hubert, Rosenzweig, Erika B, Gotzkowsky, S Karl, Arneson, Carl, Nelsen, Andrew C, Bourge, Robert C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610124/
https://www.ncbi.nlm.nih.gov/pubmed/23496856
http://dx.doi.org/10.1186/1477-7525-11-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610124/
https://www.ncbi.nlm.nih.gov/pubmed/23496856
http://dx.doi.org/10.1186/1477-7525-11-31

Ejemplares similares